Synthesis of Octahydroquinolines
(2R*,8aS*)-1-Ben zyl-3(E)-ben zyliden e-4-m eth yl-2-ph en -
yl-1,2,3,5,6,7,8,8a-octah ydr oqu in olin e (26): oily, white solid;
1H NMR (400 MHz, CDCl3) δ 7.58-7.20 (m, 15H), 6.26 (s, 1H),
4.33 (s, 1H), 4.04 (d, J ) 13.3 Hz, 1H), 3.91 (d, J ) 13.3 Hz,
1H), 2.97 (m, 1H), 2.75 (m, 1H), 1.79 (s, 3H), 1.77-0.67 (m,
7H); 13C NMR (100 MHz, CDCl3) δ 144.1, 140.8, 139.9, 139.4,
136.2, 129.6, 129.1, 129.1, 128.7, 128.2, 127.8, 127.4, 127.2,
126.8, 126.8, 121.9, 67.8, 64.2, 62.5, 36.0, 30.4, 27.0, 26.5, 18.1;
IR (CHCl3) 2850, 1720, 1590, 1480, 1440 cm-1; MS (EI) m/z
405 (M+, 73), 390 (100), 376 (10), 328 (77), 314 (11); HRMS
(EI) m/z calcd for C30H31N 405.2456, found 405.2452.
(()-Ben zyl(2(E)-ben zyliden e-3-cycloh ex-1-en yl-1-ph en yl-
bu t-3-en yl)a m in e (36): colorless oil; 1H NMR (400 MHz,
CDCl3) δ 7.40-7.12 (m, 15 H), 6.84 (s, 1H), 5.78 (s, 1H), 5.06
(s, 1H), 4.49 (s, 1H), 4.31 (s, 1H), 3.79 (AB system, J ) 13.3
Hz, 2H), 2.16 (m, 2H), 1.94 (m, 2H), 1.63 (m, 2H), 1.5 (m, 2H);
13C NMR (100 MHz, CDCl3) 148.5, 137.5, 134.3, 129.8, 129.2,
128.8, 128.6, 128.4, 128.3, 127.5, 127.3, 127.1, 127.0, 112.0,
68.3, 52.2, 26.2, 25.8, 23.2, 22.5; MS (EI) m/z 405 (M+, 80),
1H), 3.19 (t, J ) 5.7 Hz, 1H), 2.21 (m, 2H), 2.01 (m, 2H), 1.85-
1.50 (m, 6H), 1.26 (m, 8H), 0.89 (t, J ) 6.7 Hz, 3H); 13C NMR
(75 MHz, CDCl3) δ 148.5, 142.9, 141.0, 137.3, 134.3, 128.7,
128.3, 128.1, 127.9, 127.9, 126.7, 126.4, 110.7, 64.2, 51.2, 34.2,
31.9, 29.4, 26.2, 25.8, 25.7, 22.9, 22.7, 21.5, 14.1; IR (CHCl3)
3300, 2800, 1930, 1865, 1790, 1725 cm-1; MS (EI) m/z 413 (M+,
22), 328 (79), 306 (17), 91 (100); HRMS (EI) m/z calcd for
C
30H39N 413.3082, found 413.3063.
Rea ction of Vin yl Allen e 11 w ith Im in e 18. Following
the general procedure, vinyl allene 11 (125 mg, 0.77 mmol),
imine 18 (225 mg, 1.15 mmol), and BF3‚Et2O (1.1 equiv), after
3 days at 40 °C and flash chromatography (97:3 hexanes/
EtOAc), provided octahydroquinoline 29 (184 mg, 67%) and
triene 39 (16 mg, 6%).
(2R*,8aS*)-1-Ben zyl-3-isopr opyliden e-4-m eth yl-2-ph en -
yl-1,2,3,5,6,7,8,8a -octa h yd r oqu in olin e (29): white crystals;
1
mp 125-127 °C; H NMR (400 MHz, CDCl3) δ 7.53-7.14 (m,
10H), 4.60 (s, 1H), 3.77 (m, 2H), 2.77 (d, J ) 11.7 Hz, 1H),
2.68 (d, J ) 13.9 Hz, 1H), 2.07 (s, 3H), 1.99 (s, 3H), 1.60 (m,
2H), 1.55 (s, 3H), 1.45 (m, 2H), 1.09 (m, 1H), 0.75 (m, 1H),
0.66 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 143.8, 141.0, 136.2,
129.1, 128.9, 128.7, 128.1, 127.7, 127.2, 126.7, 126.0, 122.1,
63.1, 62.0, 61.2, 35.8, 29.9, 26.5, 26.0, 23.5, 21.5, 19.4; IR
(CHCl3) 3050, 3025, 3000, 2900, 2800, 1940, 1855, 1790, 1730,
1590 cm-1; MS (EI) m/z 357 (M+, 44), 342 (100), 280 (20);
HRMS (EI) m/z calcd for C26H31N 357.2456, found 357.2458.
(()-Ben zyl[2-(1-cyclohex-1-en ylvin yl)-3-m eth yl-1-ph en yl-
bu t-2-en yl]a m in e (39): colorless oil; 1H NMR (400 MHz,
CDCl3, 328K) δ 7.34-7.12 (m, 10H), 5.36 (bs, 1H), 5.09 (s, 1H),
4.86 (s, 1H), 3.73 (AB system, J ) 13.4 Hz, 2H), 2.06 (m, 1H),
1.92 (s, 3H), 1.86 (m, 3H), 1.71 (m, 2H), 1.62 (s, 3H), 1.38 (m,
4H); 13C NMR (100 MHz, CDCl3) δ 147.9, 142.7, 140.8, 135.4,
130.0, 128.2, 128.1, 127.5, 127.5, 127.4, 126.7, 126.1, 111.0,
61.3, 51.3, 25.6, 25.1, 22.9, 22.7, 21.9, 19.7; IR (CHCl3) 3000,
2900, 2750, 1725, 1580 cm-1; MS (EI) m/z 357 (M+, 48), 266
(16), 250 (28), 25 (31), 196 (72), 981 (100); HRMS (EI) m/z calcd
for C26H31N 357.2456, found 357.2445.
299 (63), 196 (62), 91 (100); HRMS (EI) m/z calcd for C30H31
N
405.2456, found 405.2495.
Rea ction of Vin yl Allen e 10 w ith Im in e 21. Following
the general procedure, vinyl allene 10 (152 mg, 0.72 mmol),
imine 21 (173 mg, 1.07 mmol), and BF3‚Et2O (1.2 equiv), after
4 days at rt and flash chromatography (97:3 hexanes/EtOAc),
provided octahydroquinoline 27 (162 mg, 61%) and triene 37
(32 mg, 12%) together with unreacted 10 (23 mg).
(2R*,8a S*)-1-Ben zyl-3(E)-b en zylid en e-2-isop r op yl-4-
m eth yl-1,2,3,5,6,7,8,8a -octa h yd r oqu in olin e (27): colorless
oil; 1H NMR (400 MHz, CDCl3) δ 7.73-7.18 (m, 10H), 6.00 (s,
1H), 3.71 (m, 2H), 2.82 (m, 2H), 2.45 (d, J ) 10.5 Hz, 1H),
2.02 (bs, 1H), 1.75 (m, 2H), 1.71 (m, 2H), 1.64 (s, 3H), 1.54
(dq, J ) 3.3, 12.6 Hz, 1H), 1.26 (m, 1H), 1.14 (m, 1H), 1.02 (d,
J ) 6.4 Hz, 3H), 0.75 (d, J ) 6.6 Hz, 3H); 13C NMR (75 MHz,
CDCl3) δ 140.7, 139.0, 138.5, 137.5, 129.2, 128.9, 127.9, 127.7,
126.6, 125.9, 123.7, 121.9, 73.8, 62.5, 62.3, 36.4, 29.4, 28.9, 26.4,
26.1, 21.0, 19.9, 17.5; IR (CHCl3) 2925, 2850, 1630, 1595 cm-1
;
MS (EI) m/z 371 (M+, 1), 329 (27), 328 (100); HRMS (EI) m/z
calcd for C27H33N 371.2613, found 371.2609.
Rea ction of Vin yl Allen e 11 w ith Im in e 21. Following
the general procedure, vinyl allene 11 (125 mg, 0.77 mmol),
imine 21 (187 mg, 1.16 mmol), and BF3‚Et2O (1.2 equiv), after
5 days at 40 °C and flash chromatography (97:3 hexanes/
EtOAc), provided octahydroquinoline 30 (93 mg, 37%) and
triene 40 (5 mg, 2%) together with unreacted 11 (19 mg).
(2R*,8a S*)-1-Ben zyl-2-isop r op yl-3-isop r op ylid en e-4-
m eth yl-1,2,3,5,6,7,8,8a -octa h yd r oqu in olin e (30): colorless
oil; 1H NMR (400 MHz, CDCl3) δ 7.40-7.19 (m, 5H), 3.53 (AB
system, J ) 13.7 Hz, 2H), 2.90 (d, J ) 10.5 Hz, 1H), 2.77 (d,
J ) 13.7 Hz, 1H), 2.66 (d, J ) 10.9 Hz, 1H), 1.90-1.62 (m,
5H), 1.92 (s, 3H), 1.82 (s, 3H), 1.62 (s, 3H), 1.45 (m, 1H), 1.16
(()-Ben zyl-(2(E)-ben zylid en e-3-cycloh ex-1-en yl-1-iso-
p r op ylbu t-3-en yl)a m in e (37): colorless oil; 1H NMR (400
MHz, CDCl3) δ 7.40-7.12 (m, 10H), 6.60 (s, 1H), 5.92 (s, 1H),
5.18 (s, 1H), 4.76 (s, 1H), 3.96 (d, J ) 13.2 Hz, 1H), 3.64 (d, J
) 13.2 Hz, 1H), 3.05 (d, J ) 3.7 Hz, 1H), 2.26 (m, 1H), 2.15
(m, 1H), 1.98 (m, 2H), 1.70-1.50 (m, 6H), 1.00 (d, J ) 6.8 Hz,
3H), 0.88 (d, J ) 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
149.5, 138.0, 134.8, 129.1, 128.7, 128.3, 128.1, 127.2, 126.9,
126.7, 124.3, 111.7, 69.1, 52.0, 30.1, 29.7, 26.2, 23.3, 22.5, 21.7,
16.4; IR (CHCl3) 2900, 2850, 1710 cm-1; MS (EI) m/z 371 (M+,
10), 328 (6), 307 (30), 289 (10), 154 (100); HRMS (EI) m/z calcd
for C27H33N 371.2613, found 371.2541.
Rea ction of Vin yl Allen e 10 w ith Im in e 22. Following
the general procedure, vinyl allene 10 (124 mg, 0.59 mmol),
imine 22 (288 mg, 1.42 mmol), and BF3‚Et2O (1.2 equiv), after
3 days at rt and flash chromatography (97:3 hexanes/EtOAc),
provided octahydroquinoline 28 (139 mg, 57%) and triene 38
(7 mg, 3%) together with unreacted 10 (6 mg).
(2R*,8a S*)-1-Ben zyl-3(E)-ben zylid en e-2-h exyl-4-m eth -
yl-1,2,3,5,6,7,8,8a -octa h yd r oqu in olin e (28): colorless oil; 1H
NMR (400 MHz, CDCl3) δ 7.43-7.18 (m, 10H), 6.06 (s, 1H),
3.74 (AB system, J ) 13.7 Hz, 2H), 2.98 (t, J ) 7.5 Hz, 2H),
2.84 (m, 1H), 1.96 (m, 1H), 1.76 (m, 3H), 1.61 (s, 3H), 1.25 (m,
10H), 0.90 (t, J ) 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
140.7, 139.1, 137.3, 129.0, 128.8, 127.7, 126.6, 126.0, 123.6,
121.3, 66.4, 62.1, 61.8, 36.5, 34.2, 31.9, 30.9, 29.6, 29.3, 26.9,
26.5, 26.3, 22.7, 17.7, 14.1; IR (CHCl3) 2800, 1940, 1870, 1790,
1720 cm-1; MS (EI) m/z 413 (M+, 3), 398 (2), 328 (100); HRMS
(EI) m/z calcd for C30H39N 413.3082, found 413.3076.
(m, 2H), 1.00 (d, J ) 6.6 Hz, 3 H), 0.66 (d, J ) 6.6 Hz, 3H); 13
C
NMR (75 MHz, CDCl3) δ 141.4, 134.4, 132.0, 129.0, 127.7,
126.4, 124.0, 122.8, 66.5, 62.1, 61.9, 36.4, 29.5, 29.3, 26.4, 26.1,
23.1, 21.5, 20.1, 20.1, 19.5; IR (CHCl3) 2850, 1935, 1860, 1795,
1730 cm-1; MS (EI) m/z 323 (M+, 2), 280 (100), 246 (2); HRMS
(EI) m/z calcd for C23H33N 323.2613, found 323.2596.
(()-Ben zyl[2-(1-cycloh ex-1-en ylvin yl)-1-isop r op yl-3-
m et h ylb u t -2-en yl]a m in e (40): colorless oil; 1H NMR (400
MHz, CDCl3) δ 7.49-7.21 (m, 5H), 5.81 (s, 1H), 5.22 (s, 1H),
4.64 (s, 1H), 3.74 (d, J ) 13.1 Hz, 1H), 3.52 (d, J ) 13.1 Hz,
1H), 3.07 (d, J ) 8.9 Hz, 1H), 2.19 (bs, 2H), 2.06 (bs, 2H), 1.71
(s, 3H), 1.66 (s, 3H), 1.53 (m, 5H), 0.98 (d, J ) 6.6 Hz, 3H),
0.81 (d, J ) 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 148.6,
128.2, 128.0, 127.6, 126.6, 126.0, 114.6, 64.5, 52.4, 31.6, 29.7,
25.8, 23.2, 23.0, 22.2, 20.9, 20.2, 19.9.
Rea ction of Vin yl Allen e 11 w ith Im in e 22. Following
the general procedure, vinyl allene 11 (125 mg, 0.77 mmol),
imine 22 (373 mg, 1.84 mmol), and BF3‚Et2O (1.2 equiv), after
5 days at 40 °C and flash chromatography (97:3 hexanes/
EtOAc), provided octahydroquinoline 31 (115 mg, 41%) and
triene 41 (20 mg, 7%) together with unreacted 11 (29 mg).
(2R*,8a S*)-1-Ben zyl-2-h exyl-3-isop r op ylid en e-4-m eth -
yl-1,2,3,5,6,7,8,8a -octa h yd r oqu in olin e (31): colorless oil; 1H
(()-Ben zyl[1-(1(E)-ben zylid en e-2-cycloh ex-1-en yla llyl)-
h ep tyl]a m in e (38): colorless oil; 1H NMR (300 MHz, CDCl3)
δ 7.43-7.13 (m, 10H), 6.55 (s, 1H), 5.93 (s, 1H), 5.23 (s, 1H),
4.81 (s, 1H), 3.90 (d, J ) 13.2 Hz, 1H), 3.70 (d, J ) 13.2 Hz,
J . Org. Chem, Vol. 68, No. 20, 2003 7851